Literature DB >> 6443699

Properties of human interleukin-2 receptors expressed on non-lymphoid cells by cDNA transfection.

H Sabe, S Kondo, A Shimizu, Y Tagaya, J Yodoi, N Kobayashi, M Hatanaka, N Matsunami, M Maeda, T Noma.   

Abstract

We have established non-lymphoid cell lines HeLa, Ltk and NIH3T3 expressing the human interleukin-2 (IL-2) receptor by transfection of human IL-2 receptor complementary DNA. While IL-2 receptors on T cells are classified into the high and low affinity species, the receptors expressed on the cDNA-transfected non-lymphoid cells belong to the low affinity species. These IL-2 receptors could not transmit the growth signal although they were similar in size to those expressed on T cells. Phorbol ester-induced phosphorylation of the IL-2 receptors on HeLa cells did not affect the affinity of the receptor. We have also constructed a cDNA encoding a mutant IL-2 receptor that replaced the major phosphorylation site, the serine residue at position 247 with the glycine residue. This mutant IL-2 receptor expressed on non-lymphoid cells also had the low affinity for IL-2. The results indicate that the high and low affinity states of the IL-2 receptor are not solely determined by phosphorylation of the receptor. The IL-2 receptors expressed on these non-lymphoid cells were internalized four to eight times more slowly than those on T cells. Possible defects of the IL-2 receptors expressed on non-lymphoid cells are discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6443699

Source DB:  PubMed          Journal:  Mol Biol Med        ISSN: 0735-1313


  14 in total

1.  Molecular basis for two different affinity states of the interleukin 2 receptor: affinity conversion model.

Authors:  S Kondo; A Shimizu; Y Saito; M Kinoshita; T Honjo
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

2.  The human interleukin-2 receptor beta-chain gene: genomic organization, promoter analysis and chromosomal assignment.

Authors:  H Shibuya; M Yoneyama; Y Nakamura; H Harada; M Hatakeyama; S Minamoto; T Kono; T Doi; R White; T Taniguchi
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

3.  Translation of NRF mRNA is mediated by highly efficient internal ribosome entry.

Authors:  A Oumard; M Hennecke; H Hauser; M Nourbakhsh
Journal:  Mol Cell Biol       Date:  2000-04       Impact factor: 4.272

4.  Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes.

Authors:  Y Nakamura; T Inamoto; K Sugie; H Masutani; T Shindo; Y Tagaya; A Yamauchi; K Ozawa; J Yodoi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

5.  Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).

Authors:  T Shindo; K Sugie; K Nakamura; Y Tagaya; M Maeda; T Uchiyama; K Sagawa; M Yokoyama; H Wada; S Hitomi
Journal:  Immunology       Date:  1990-09       Impact factor: 7.397

6.  IL-2 receptor expression in human lymphoid lesions. Immunohistochemical study of 166 cases.

Authors:  J A Strauchen; B A Breakstone
Journal:  Am J Pathol       Date:  1987-03       Impact factor: 4.307

7.  Regulation of interleukin 2-dependent growth responses by glycosylphosphatidylinositol molecules.

Authors:  I Merida; J C Pratt; G N Gaulton
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

8.  Intermediate- and high-affinity interleukin-2 receptors expressed in an IL-4-dependent T-cell line induce different signals.

Authors:  A Rebollo; A Silva
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

9.  Monoclonal antibody defining a molecule possibly identical to the p75 subunit of interleukin 2 receptor.

Authors:  T Takeshita; Y Goto; K Tada; K Nagata; H Asao; K Sugamura
Journal:  J Exp Med       Date:  1989-04-01       Impact factor: 14.307

10.  A larger number of L chains (Tac) enhance the association rate of interleukin 2 to the high affinity site of the interleukin 2 receptor.

Authors:  Y Saito; H Sabe; N Suzuki; S Kondo; T Ogura; A Shimizu; T Honjo
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.